Cart
sales@molnova.com
SU5402
CAS No. 215543-92-3
SU5402( SU5402 | SU-5402 | SU 5402 )
Catalog No. M17435 CAS No. 215543-92-3
SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 53 | In Stock |
|
| 10MG | 84 | In Stock |
|
| 25MG | 152 | In Stock |
|
| 50MG | 255 | In Stock |
|
| 100MG | 410 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU5402
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.
-
DescriptionSU5402 is a potent and selective vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) inhibitor (IC50 values are 0.02, 0.03, 0.51 and > 100 μ M at VEGFR2, FGFR1, PDGFR β and EGFR respectively).
-
In Vitro——
-
In Vivo——
-
SynonymsSU5402 | SU-5402 | SU 5402
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorFGFR1| PDGFRβ| VEGFR2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number215543-92-3
-
Formula Weight296.32
-
Molecular FormulaC17H16N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 30 mg/mL; 101.24 mM
-
SMILESCC1=CNC(=C1CCC(=O)O)/C=C\2/C3=CC=CC=C3NC2=O
-
Chemical Name(Z)-3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid.
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Chrysophanic Acid
Extracted from Rheum palmatum L.;Suitability:Boiling ethanol,benzene,chloroform,ether,acetic acid and acetone.
-
Lapatinib
A reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.
-
RO 46-8443
RO 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. RO 46-8443 displays up to 2000-fold selectivity for ETB receptors both in terms of binding inhibitory potency and functional inhibition.
